EXCHANGE AGREEMENTExchange Agreement • January 13th, 2022 • Eledon Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Exchange Agreement (the “Agreement”), dated as of January 11, 2022 (the “Effective Date”), is entered into by and among Eledon Pharmaceuticals, a Delaware corporation (the “Company”), and the holders of the Company’s common stock, par value $0.001 per share (the “Common Stock”) listed on Schedule I attached hereto (each a “Stockholder” and collectively, the “Stockholders” and, together with the Company, the “Parties”).
